Creative Drug Pricing Hindered By Medicaid Best Price, Stakeholders Say

Requirement that drug manufacturers pay Medicaid rebates based on the best price available to any purchaser impedes payer efforts to negotiate value-based pricing for costly drugs, Pfizer and Express Scripts say.

More from United States

More from North America